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Abstract
Arsenic (+3 oxidation state) methyltransferase is the key enzyme in the methylation pathway for 
inorganic arsenic. We have recently shown that As3mt knockout (KO) has a profound effect on 
metabolomic profiles in mice. Phosphatidylcholine species (PCs) were the largest group of 
metabolites altered in both plasma and urine. The present study used targeted analysis to 
investigate the KO-associated changes in PC profiles in the liver, the site of PC synthesis. Results 
show that As3mt KO has a systemic effect on PC metabolism and that this effect is sex dependent.
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Introduction
Inorganic arsenic (iAs) exposure through drinking water affects millions of people 
worldwide and is implicated in multiple cancers as well as non-cancer diseases. In humans, 
iAs is enzymatically methylated to mono- and dimethylated metabolites that are excreted 
mainly in urine (Thomas et al. 2007). Methylation of iAs is catalyzed by arsenic (+3 
oxidation state) methyltransferase (AS3MT). Polymorphisms in AS3MT have been found to 
be associated with altered iAs metabolism and differing risks of cancer and metabolic 
disease (Antonelli et al. 2014). Thus, the As3mt-knockout (KO) mouse that cannot 
methylate iAs is a useful model for assessing the role of iAs metabolism in disease 
associated with iAs exposure. However, apart from the inability to methylate arsenic, the 
metabolism of the As3mt-KO mice has been poorly characterized.
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Recently, we published a study comparing the urinary and plasma metabolomes of C57BL/6 
mice (WT) and As3mt-KO mice (Huang et al. 2016), with and without exposure to iAs. 
While we found few metabolites to be changed due to iAs treatment in either mouse strain, 
we found more significantly changed metabolites in comparisons of WT and KO animals, 
particularly among phosphatidylcholines (PCs) and other metabolites related to lipid 
metabolism.
PCs are primary components of cellular membranes, are precursors to signaling molecules, 
and make up 60–80 % of the phospholipid component of plasma lipoproteins (Cole et al. 
2012). All nucleated cells synthesize PCs, but the liver is a major site for PC synthesis and 
plasma lipoprotein assembly (Cole et al. 2012). Notably, methylation of iAs occurs primarily 
in the liver (Watanabe and Hirano 2013), making it a target organ for iAs toxicity. The liver 
of As3mt-KO mice is particularly susceptible because it accumulates iAs (Currier et al. 
2016; Hughes et al. 2010). To further probe the effects of As3mt KO on PC metabolism, we 
measured concentrations of molecular PC species in livers from mice in our recent 
metabolomic study and compared hepatic PCs profiles with those previously found in 
plasma.
Materials and methods
Animals and treatment
In the metabolomic study, adult male and female C57BL/6J WT and As3mt-KO mice were 
exposed to 0 and 1 ppm As as arsenite in drinking water for 4 weeks (N = 15–21/group) 
(Huang et al. 2016). Right medial lobes of the livers were collected at killing, snap-frozen in 
liquid nitrogen, and stored at −80 °C until analyzed.
PC analysis
Liver tissue homogenate (150 μg protein) was extracted as previously described (Bligh and 
Dyer 1959) except substituting dichloromethane for chloroform. An internal standard 1,2-
dimyristoyl-sn-glycero-3-phosphocholine (1.0 μg, Avanti Polar Lipids, Alabaster, AL) was 
added to the organic layer, and an aliquot (10 %) was injected into a tandem quadrupole 
mass spectrometer for continuous electrospray ionization (positive ions). Precursor ions of 
m/z 184 were measured for analysis of PC molecular species (Han et al. 2012) and 
quantitated using LipidView (Simons et al. 2012). Signals for molecular species of PC were 
ratioed to the signal from the internal standard.
Data analysis
The relative concentrations of PC species were analyzed as described in our metabolomic 
study, using Partek for hierarchical clustering analysis and for ANCOVA analysis with sex, 
genotype, and iAs treatment as covariates (Huang et al. 2016). A p value cutoff at p < 0.05 
and a false-discovery rate q value cutoff of q < 0.1 were used to determine PC species 
significantly changed due to genotype, sex or iAs treatment.
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Results and discussion
Twenty-nine PC species were identified in livers from all treatment groups. These species 
clustered primarily due to sex, followed by genotype, and not due to iAs treatment (Suppl. 
Figure 1). There were only 1–3 significantly changed hepatic PCs in comparisons of 0 ppm 
(untreated) and 1 ppm groups (Suppl. Table 1). These results are consistent with the major 
effect of sex and only minor effects of iAs exposure on plasma and urine metabolomes 
found in our metabolomic study (Huang et al. 2016).
As3mt KO changed greater numbers of hepatic PCs than did iAs exposure, but the extent of 
these changes differed between male and female mice. In untreated mice, more hepatic PCs 
were changed due to KO in male as compared to female mice (12 vs. 4), and this trend was 
also seen in iAs-treated mice (9 vs. 8) (Fig. 1a). Conversely, in the plasma, more PCs were 
changed due to As3mt KO in female as compared to male mice in both unexposed (48 vs. 
14) and exposed groups (16 vs. 12) (Fig. 1b). In addition, As3mt KO affected different PCs 
in males and different PCs in females. Only one hepatic PC, PC (38:3), was increased due to 
KO in both male and female untreated mice; in iAs-treated mice, two PCs were changed—
PC (38:3) increased and PC (32:0) decreased—in both males and females (Figs. 1a, 2). In 
plasma, only eight PCs were changed in both untreated males and females due to KO and 
only five PCs in iAs-treated mice (Fig. 1b). The fold change of PC concentrations in KO 
mice did not exceed 1.6; however, great numbers of PCs in both liver and plasma were 
affected (Fig. 1; Suppl. Table 2). Taken together, these results suggest that As3mt KO has a 
major effect on PC metabolism and that this effect is sex dependent.
The KO- or sex-associated changes in hepatic and plasma PC profiles may reflect alterations 
in hepatic PC synthesis (Vance 2008), export (Robins et al. 1991), or in PC remodeling 
(Hermansson et al. 2011), as well as in use of PCs as precursors to signaling molecules 
(Cole et al. 2012). Any combination of these processes could underlie the observed changes 
in PC profiles. Notably, in all of the KO vs WT comparisons, some PC species were 
significantly changed in both plasma and liver (Table 1). In particular, PC (38:3) was found 
changed (increased) due to KO in both plasma and liver of both untreated and iAs-treated 
male and female mice (Fig. 2). Future studies should examine the fatty acid tail composition 
and metabolism of PC (38:3) in iAs-exposed mice. With further characterization, this PC 
species may serve as a biomarker of iAs exposure or of iAs methylation capacity.
In conclusion, we found differences in hepatic PCs of WT and As3mt-KO mice that 
paralleled our previous findings in urinary and plasma metabolomes. While only minor 
differences in hepatic PCs were linked with iAs treatment, major changes in PCs were 
associated with As3mt KO, in a sex-specific manner. Notably, some As3mt-KO-associated 
PCs were found in both plasma and liver, suggesting that the effects of As3mt KO on PCs 
are systemic. These results are a further step in understanding the role iAs metabolism plays 
in adverse effects of iAs exposure.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. 
Number of hepatic (a) and plasma (b) PC species significantly changed (p < 0.05) in 
comparisons of As3mt-knockout (KO) and wild-type (WT) control and iAs-treated mice. 
Bolded numbers indicate total number of PCs changed in each comparison, for the 
compartment; arrows indicate increase or decrease of PCs in KO mice
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Fig. 2. 
Relative abundance of the phosphatidylcholine (PC) species (C38:3 in liver (a) and plasma 
(b) of wild-type (WT) and As3mt-knockout (KO), untreated (0 ppm) and iAs-treated (1 
ppm), male (M) and female (F) mice; *p < 0.05 and q < 0.01
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Table 1
Phosphatidylcholine (PC) species significantly changed in comparisons of As3mt-knockout (KO) and wild-
type (WT) mice in both plasma and liver
Comparison PC speciesa Fold changeb in plasma Fold change in liver
Untreated females
KO versus WT
PC (C38:3) 1.34 1.23
PC (C38:4) 1.27 1.12
PC (C40:4) 1.26 1.50
Untreated males
KO versus WT
PC (C32:1) 1.47 1.21
PC (C38:3) 1.33 1.22
PC (O-C40:6) −1.25 −1.30
iAs-treated females
KO versus WT
PC (C38:3) 1.29 1.16
PC (C36:2) 1.17 1.21
iAs-treated males
KO versus WT
PC (C32:1) 1.51 1.35
PC (C36:5) 1.16 1.19
PC (C38:3) 1.29 1.42
PC (C40:4) 1.23 1.26
PC (O-C36:2) −1.18 −1.36
PC (O-C40:6) −1.49 −1.36
a
Phosphatidylcholine notation: PC(X:Y) indicates a phosphatidylcholine X total carbons and Y double bonds. PC(O-X:Y) indicates a 
phosphatidylcholine with one acyl and one ester linkage to the fatty acid tails with X total carbons and Y double bonds
b
Fold change indicates an increase or decrease in KO animals
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